Medigene (MDG1) News Today → My #1 investment for 2024 (From True Market Insiders) (Ad) Free MDG1 Stock Alerts €1.40 -0.01 (-0.71%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartHeadlinesStock AnalysisChartHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 15 at 6:36 PM | finanznachrichten.deMedigene AG: Medigene Presents Preclinical Data on Optimal Affinity TCRs Targeting the Neoantigen Mutant KRASMay 15 at 6:36 PM | finance.yahoo.comMedigene Presents Preclinical Data on Optimal Affinity TCRs Targeting the Neoantigen Mutant KRASMay 14, 2024 | finance.yahoo.comMedigene AG Extends Cash Runway into July 2025 After Successful Oversubscribed Capital RaiseMay 2, 2024 | markets.businessinsider.comMedigene Presents Superior TCR-T Cell Functionality by Inclusion of a Costimulatory Switch ProteinApril 26, 2024 | finance.yahoo.comMedigene AG reports Financial Results and Business Update for Q1 2024April 25, 2024 | finance.yahoo.comMedigene presents streamlined 6-day, high stemness TCR-T therapy production processApril 22, 2024 | finanznachrichten.dePTA-Adhoc: Medigene AG: Medigene AG führt Bezugsrechtskapitalerhöhung mit Backstop-Vereinbarung durchApril 17, 2024 | finance.yahoo.comMedigene to Present at Upcoming Scientific ConferencesApril 8, 2024 | finance.yahoo.comMedigene Presents Favorable Safety Profile of TCR-T Cells with Costimulatory Switch Protein at AACR Annual Meeting 2024April 4, 2024 | finanznachrichten.deMedigene: 2024 steht im Zeichen von MDG1015, BioNTech und der FinanzierungApril 4, 2024 | finanznachrichten.dePTA-News: Medigene AG: Medigene AG sichert sich europäisches Patent für ihre iM-TCR-TechnologieApril 4, 2024 | finance.yahoo.comMedigene AG Secures European Patent for its iM-TCR TechnologyMarch 28, 2024 | finanznachrichten.dePTA-News: Medigene AG: Medigene AG gibt Finanzergebnisse für das Geschäftsjahr 2023 und Unternehmens-Update bekanntMarch 28, 2024 | finanznachrichten.dePTA-News: Medigene AG: Medigene AG gibt -2-March 26, 2024 | finance.yahoo.comWe Think Medigene (ETR:MDG1) Needs To Drive Business Growth CarefullyMarch 19, 2024 | finanznachrichten.dePTA-News: Medigene AG: Medigene AG nimmt an der H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference teilMarch 18, 2024 | finanznachrichten.dePTA-News: Medigene AG: Medigene AG veröffentlicht Finanzergebnisse für das Geschäftsjahr 2023 am 28. März 2024March 18, 2024 | finance.yahoo.comMedigene AG to report full year 2023 financial results on March 28, 2024March 6, 2024 | finance.yahoo.comMedigene to Present Favorable Safety Profile of TCR-T Cells upon Addition of Costimulatory Switch Protein with a Poster Presentation at AACR 2024 Annual MeetingMarch 4, 2024 | finanznachrichten.dePTA-News: Medigene AG: Medigene erweitert Patentportfolio in Japan um iM-TCR-Technologie zur Kontrolle der TCR-T-Sicherheit und -WirksamkeitFebruary 29, 2024 | finanznachrichten.deMedigene AG: Medigene Presents at CAR-TCR Summit Europe Showcasing Unique Approach for Development of Differentiated TCR-T TherapiesFebruary 29, 2024 | finanznachrichten.dePTA-News: Medigene AG: Medigene zeigt auf dem CAR-TCR Summit Europe innovative Ansätze zur Entwicklung differenzierter TCR-T-TherapienFebruary 29, 2024 | markets.businessinsider.comMedigene Presents at CAR-TCR Summit Europe Showcasing Unique Approach for Development of Differentiated TCR-T TherapiesFebruary 19, 2024 | finanznachrichten.dePTA-News: Medigene AG: Medigene präsentiert auf folgenden KonferenzenFebruary 19, 2024 | finance.yahoo.comMedigene to Present at Upcoming ConferencesFebruary 12, 2024 | finanznachrichten.dePTA-News: Medigene AG: Medigene gibt Auswahl der Anwendungsgebiete für die klinische Entwicklung der TCR-T-Therapie bei soliden Tumoren bekanntFebruary 12, 2024 | finanznachrichten.deMedigene AG: Medigene Announces Indication Selection for the Clinical Development of its Lead 3rd Generation TCR-T Therapy Program in Solid TumorsFebruary 12, 2024 | uk.finance.yahoo.comMedigene Announces Indication Selection for the Clinical Development of its Lead 3rd Generation TCR-T Therapy Program in Solid TumorsFebruary 12, 2024 | finance.yahoo.comMedigene Announces Indication Selection for the Clinical Development of its Lead 3rd Generation TCR-T Therapy Program in Solid TumorsJanuary 2, 2024 | morningstar.comMedigene AG Namen-Akt. nach KapitalherabsetzungDecember 19, 2023 | finanznachrichten.dePTA-News: Medigene AG: Medigene AG nimmt an der 42. Jahrestagung der J.P. Morgan Healthcare Conference teilDecember 19, 2023 | finance.yahoo.comMedigene AG to attend at the 42nd Annual J.P. Morgan Healthcare ConferenceNovember 21, 2023 | finance.yahoo.comMedigene amends 2023 financial guidanceNovember 21, 2023 | finance.yahoo.comMedigene AG Announces Prioritization of Pipeline and Resource Allocation as well as Extension of Cash RunwayNovember 4, 2023 | finance.yahoo.comMedigene presents new data for MDG2011, the first TCR in a novel KRAS library, demonstrating capability of its proprietary E2E Platform to generate multiple enhanced TCR-T therapies against mKRAS G12V A*11October 26, 2023 | finance.yahoo.comMedigene Reports Financial Results and Corporate Update for Q3 2023October 25, 2023 | finance.yahoo.comMedigene AG (MDG1.HA)October 25, 2023 | finance.yahoo.comAGC Biologics Signs TCR-T Cell Services Agreement to Support Medigene’s New Cell Therapy ProductOctober 24, 2023 | finanznachrichten.dePTA-News: Medigene AG: Medigene stellt erste präklinische Daten zu mKRAS G12V kombiniert mit dem PD1-41BB kostimulatorischen Switch-Protein vorOctober 23, 2023 | finanznachrichten.dePTA-News: Medigene AG: Medigene stellt erste -2-October 23, 2023 | finance.yahoo.comMedigene presents first pre-clinical data of optimal affinity TCR targeting mKRAS G12V combined with a PD1-41BB costimulatory switch protein showing enhanced and sustained tumor killingOctober 16, 2023 | finance.yahoo.comMedigene to present new pre-clinical data for pipeline TCR-T therapies at the ESMO Congress 2023October 15, 2023 | finance.yahoo.comWe're Keeping An Eye On Medigene's (ETR:MDG1) Cash Burn RateSeptember 27, 2023 | finance.yahoo.comMedigene AG Secures European Patent for its PD1-41BB Costimulatory Switch ProteinSeptember 27, 2023 | finance.yahoo.comMedigene AG Secures European Patent for its PD1-41BB Costimulatory Switch ProteinSeptember 18, 2023 | finanznachrichten.dePTA-News: Medigene AG: Medigene AG gibt Auswahl des Leitkandidaten für MDG2011 und damit die erste TCR-T-Therapie ihrer KRAS-Bibliothek bekanntSeptember 18, 2023 | finance.yahoo.comMedigene AG Announces Lead Selection for MDG2011 Representing the First TCR-T Therapy of its KRAS LibrarySeptember 11, 2023 | finanznachrichten.dePTA-News: Medigene AG: Medigene AG präsentiert auf der Baader Investment Conference 2023September 11, 2023 | finance.yahoo.comMedigene AG to present at the Baader Investment Conference 2023September 5, 2023 | finanznachrichten.dePTA-News: Medigene AG: Medigene AG präsentiert auf der 25. H.C. Wainwright Annual Global Investment Conference Get Medigene News Delivered to You Automatically Sign up to receive the latest news and ratings for MDG1 and its competitors with MarketBeat's FREE daily newsletter. Email Address get a piece of the profit from this land (Ad)This isn’t the prettiest land on earth. But it might be the most valuable. And you don’t have to own, lease, or rent any land. Click here to see my #1 investment for 2024. MDG1 Media Mentions By Week MDG1 Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MDG1 News Sentiment▼0.240.50▲Average Medical News Sentiment MDG1 News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MDG1 Articles This Week▼31▲MDG1 Articles Average Week Get Medigene News Delivered to You Automatically Sign up to receive the latest news and ratings for MDG1 and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Genfit News Today MorphoSys News Today Fielmann Group News Today Fresenius SE & Co. KGaA News Today Sanofi News Today Sartorius Aktiengesellschaft News Today Sartorius Stedim Biotech News Today Drägerwerk AG & Co. KGaA News Today Stratec News Today CompuGroup Medical SE & Co. KGaA News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ETR:MDG1) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersObama’s Forever Term [exposed]Porter & Company4 Cryptos BETTER than BitcoinTrue Market InsidersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingElon’s New Device is About to Shock the WorldInvestorPlaceMissed NVDA? Buy this AI stock NOWChaikin AnalyticsProtect Your Bank Account Before It’s Too LateWeiss RatingsUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medigene AG Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.